Estrella Immunopharma Stock Buy Hold or Sell Recommendation
| ESLAW Stock | 0.09 0.00 0.00% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Estrella Immunopharma is 'Strong Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Estrella Immunopharma given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Estrella Immunopharma, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Estrella Immunopharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Estrella Stock please use our How to Invest in Estrella Immunopharma guide. Note, we conduct extensive research on individual companies such as Estrella and provide practical buy, sell, or hold advice based on investors' constraints. Estrella Immunopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Estrella |
Execute Estrella Immunopharma Buy or Sell Advice
The Estrella recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Estrella Immunopharma. Macroaxis does not own or have any residual interests in Estrella Immunopharma or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Estrella Immunopharma's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Good | Details | |
Volatility | Out of control | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Moves completely opposite to the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Estrella Immunopharma Trading Alerts and Improvement Suggestions
| Estrella Immunopharma is way too risky over 90 days horizon | |
| Estrella Immunopharma has some characteristics of a very speculative penny stock | |
| Estrella Immunopharma appears to be risky and price may revert if volatility continues | |
| Estrella Immunopharma has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (7.31 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Estrella Immunopharma generates negative cash flow from operations | |
| Estrella Immunopharma has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Estrella Immunopharma, Inc. Receives Buy Rating With a Price Target of 14.00 From CB Capital Partners - Yahoo Finance |
Estrella Immunopharma Returns Distribution Density
The distribution of Estrella Immunopharma's historical returns is an attempt to chart the uncertainty of Estrella Immunopharma's future price movements. The chart of the probability distribution of Estrella Immunopharma daily returns describes the distribution of returns around its average expected value. We use Estrella Immunopharma price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Estrella Immunopharma returns is essential to provide solid investment advice for Estrella Immunopharma.
| Mean Return | 3.56 | Value At Risk | -44.91 | Potential Upside | 71.07 | Standard Deviation | 30.05 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Estrella Immunopharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Estrella Immunopharma Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Estrella Immunopharma or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Estrella Immunopharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Estrella stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 3.15 | |
β | Beta against Dow Jones | -3.65 | |
σ | Overall volatility | 20.87 | |
Ir | Information ratio | 0.12 |
Estrella Immunopharma Volatility Alert
Estrella Immunopharma is showing large volatility of returns over the selected time horizon. Estrella Immunopharma is a penny stock. Although Estrella Immunopharma may be in fact a good investment, many penny stocks are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in Estrella Immunopharma. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on Estrella instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Estrella Immunopharma Fundamentals Vs Peers
Comparing Estrella Immunopharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Estrella Immunopharma's direct or indirect competition across all of the common fundamentals between Estrella Immunopharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as Estrella Immunopharma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Estrella Immunopharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing Estrella Immunopharma by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Estrella Immunopharma to competition |
| Fundamentals | Estrella Immunopharma | Peer Average |
| Return On Asset | -1.75 | -0.14 |
| Number Of Shares Shorted | 19.25 K | 4.71 M |
| EBITDA | (7.31 M) | 3.9 B |
| Net Income | (7.31 M) | 570.98 M |
| Total Debt | 180.7 K | 5.32 B |
| Book Value Per Share | (2.89) X | 1.93 K |
| Cash Flow From Operations | (16.07 M) | 971.22 M |
| Beta | -0.09 | -0.15 |
| Total Asset | 4.45 M | 29.47 B |
| Retained Earnings | (19.5 M) | 9.33 B |
| Working Capital | 4.27 M | 1.48 B |
| Net Asset | 4.45 M |
Estrella Immunopharma Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Estrella . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Estrella Immunopharma Buy or Sell Advice
When is the right time to buy or sell Estrella Immunopharma? Buying financial instruments such as Estrella Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Estrella Immunopharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Defense Thematic Idea Now
Defense
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Defense theme has 15 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Defense Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Estrella Stock Analysis
When running Estrella Immunopharma's price analysis, check to measure Estrella Immunopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Estrella Immunopharma is operating at the current time. Most of Estrella Immunopharma's value examination focuses on studying past and present price action to predict the probability of Estrella Immunopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Estrella Immunopharma's price. Additionally, you may evaluate how the addition of Estrella Immunopharma to your portfolios can decrease your overall portfolio volatility.